Kry vs Revvity
Side-by-side comparison of AI visibility scores, market position, and capabilities
Kry (Livi in UK/France) is Europe's leading digital primary care platform with $2B valuation; operates 60+ clinics; raised €516M total from Accel, Index Ventures, and Creandum;
About
Kry is a Swedish digital healthcare company founded in 2014 by Johannes Schildt and headquartered in Stockholm. It operates under the brand Kry in Sweden, Norway, and Germany, and as Livi in the UK and France. The company provides a hybrid primary care platform that combines on-demand video consultations — connecting patients with licensed physicians, nurses, and specialists within minutes through its app — with a network of 60+ physical primary care clinics where patients can book in-person appointments. This dual model enables Kry to serve the full spectrum of primary care needs, from acute digital triage to chronic disease management and preventive care.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
About
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.